S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.49 (+1.44%)
MSFT   212.81 (+1.29%)
FB   276.85 (+3.14%)
GOOGL   1,761.36 (+1.96%)
AMZN   3,118.18 (+0.64%)
TSLA   558.23 (+6.97%)
NVDA   520.01 (-1.06%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.41 (+3.38%)
MU   63.56 (-0.97%)
AMD   85.17 (-0.16%)
T   29.22 (+2.10%)
NIO   53.91 (-2.65%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.98 (+1.12%)
GILD   60.61 (+1.20%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.49 (+1.44%)
MSFT   212.81 (+1.29%)
FB   276.85 (+3.14%)
GOOGL   1,761.36 (+1.96%)
AMZN   3,118.18 (+0.64%)
TSLA   558.23 (+6.97%)
NVDA   520.01 (-1.06%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.41 (+3.38%)
MU   63.56 (-0.97%)
AMD   85.17 (-0.16%)
T   29.22 (+2.10%)
NIO   53.91 (-2.65%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.98 (+1.12%)
GILD   60.61 (+1.20%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.49 (+1.44%)
MSFT   212.81 (+1.29%)
FB   276.85 (+3.14%)
GOOGL   1,761.36 (+1.96%)
AMZN   3,118.18 (+0.64%)
TSLA   558.23 (+6.97%)
NVDA   520.01 (-1.06%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.41 (+3.38%)
MU   63.56 (-0.97%)
AMD   85.17 (-0.16%)
T   29.22 (+2.10%)
NIO   53.91 (-2.65%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.98 (+1.12%)
GILD   60.61 (+1.20%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.49 (+1.44%)
MSFT   212.81 (+1.29%)
FB   276.85 (+3.14%)
GOOGL   1,761.36 (+1.96%)
AMZN   3,118.18 (+0.64%)
TSLA   558.23 (+6.97%)
NVDA   520.01 (-1.06%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.41 (+3.38%)
MU   63.56 (-0.97%)
AMD   85.17 (-0.16%)
T   29.22 (+2.10%)
NIO   53.91 (-2.65%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.98 (+1.12%)
GILD   60.61 (+1.20%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
Log in
NASDAQ:ONCE

Spark Therapeutics Price Target, Predictions & Analyst Ratings

Notice: This company has been marked as potentially delisted and may not be actively trading.
$113.57
0.00 (0.00 %)
(As of 12/26/2019)
Add
Compare
Today's Range
$113.57
Now: $113.57
$113.57
50-Day Range
$110.05
MA: $113.43
$113.57
52-Week Range
$34.53
Now: $113.57
$114.20
Volume8,720 shs
Average Volume891,560 shs
Market Capitalization$4.38 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.05

Analyst Ratings

Spark Therapeutics (NASDAQ:ONCE) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for Spark Therapeutics in the last 12 months. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
ONCE Consensus Rating: HoldHoldHoldHold
ONCE Consensus Rating Score: 2.002.002.002.00
ONCE Analyst Ratings: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
ONCE Consensus Price Target: N/AN/AN/A$114.50
ONCE Price Target Upside: N/AN/AN/A14.32% upside

Spark Therapeutics (NASDAQ:ONCE) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Spark Therapeutics (NASDAQ:ONCE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/17/2019William BlairReiterated RatingHoldLow
8/12/2019MizuhoReiterated RatingHold$114.50High
3/25/2019BarclaysDowngradeOverweight ➝ Equal Weight$74.00 ➝ $115.00Low
2/27/2019Stifel NicolausDowngradeBuy ➝ Hold$65.00 ➝ $114.50Low
2/26/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$85.00 ➝ $114.50Low
2/26/2019Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$113.48Low
2/26/2019BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$46.00 ➝ $114.50Low
2/25/2019Raymond JamesDowngradeStrong-Buy ➝ Market PerformLow
2/25/2019SunTrust BanksDowngradeBuy ➝ HoldN/A
2/25/2019Cantor FitzgeraldDowngradeOverweight ➝ Neutral$80.00 ➝ $114.50N/A
2/19/2019Credit Suisse GroupReiterated RatingHold$47.00Low
11/7/2018B. RileyUpgradeNeutral ➝ Buy$68.00 ➝ $71.00High
11/7/2018WedbushUpgradeUnderperform ➝ Neutral$40.00 ➝ $40.00High
11/7/2018JPMorgan Chase & Co.Reiterated RatingHold$60.00High
10/9/2018GuggenheimInitiated CoverageBuy ➝ Buy$70.00High
8/8/2018UBS GroupLower Price TargetNeutral ➝ Neutral$80.00 ➝ $53.00Medium
8/8/2018Royal Bank of CanadaLower Price TargetSector Perform$64.00High
8/8/2018Chardan CapitalBoost Price TargetNeutral$60.00 ➝ $85.00Medium
8/7/2018SVB LeerinkReiterated RatingMarket Perform$74.00 ➝ $55.00Medium
8/7/2018CitigroupUpgradeNeutral ➝ BuyHigh
5/8/2018CowenReiterated RatingBuy$85.00High
12/14/2017The Goldman Sachs GroupDowngradeBuy ➝ Neutral$106.00 ➝ $58.00Low
(Data available from 11/24/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.